18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy
J Tseng, LK Dunnwald, EK Schubert… - Journal of Nuclear …, 2004 - Soc Nuclear Med
The aim of this study was to characterize the biologic response of locally advanced breast
cancer (LABC) to chemotherapy using 15O-water–derived blood flow measurements and …
cancer (LABC) to chemotherapy using 15O-water–derived blood flow measurements and …
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy
DA Mankoff, LK Dunnwald, JR Gralow… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant
chemotherapy followed by definitive surgery. The factors influencing the response of LABC …
chemotherapy followed by definitive surgery. The factors influencing the response of LABC …
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy
DA Mankoff, LK Dunnwald, JR Gralow… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant
chemotherapy followed by definitive surgery. The factors influencing the response of LABC …
chemotherapy followed by definitive surgery. The factors influencing the response of LABC …
18F-FDG PET–derived tumor blood flow changes after 1 cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer
O Humbert, JM Riedinger, JM Vrigneaud… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Previous studies have suggested that early changes in blood flow (BF) in response to
neoadjuvant chemotherapy and evaluated with 15O-water are a surrogate biomarker of …
neoadjuvant chemotherapy and evaluated with 15O-water are a surrogate biomarker of …
Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors
A Cochet, S Pigeonnat, B Khoury… - Journal of Nuclear …, 2012 - Soc Nuclear Med
The purpose of this study was to prospectively evaluate the relationship between tumor
blood flow and glucose metabolism as evaluated by dynamic first-pass 18F-FDG PET and …
blood flow and glucose metabolism as evaluated by dynamic first-pass 18F-FDG PET and …
Breast cancer blood flow and metabolism on dual-acquisition 18F-FDG PET: correlation with tumor phenotype and neoadjuvant chemotherapy response
O Humbert, M Lasserre, A Bertaut… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Early changes in tumor glucose metabolism (SUVmax) and in tumor blood flow (BF) have
been evaluated separately for monitoring breast cancer response to neoadjuvant …
been evaluated separately for monitoring breast cancer response to neoadjuvant …
FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers
The aim of this study was to determine the relationship between tumor blood flow and
glucose utilization in women with untreated primary breast carcinomas. Noninvasive …
glucose utilization in women with untreated primary breast carcinomas. Noninvasive …
18F-FDG retention index and biologic prognostic parameters in breast cancer
AMG Vicente, ÁS Castrejón, FR Calatayud… - Clinical Nuclear …, 2012 - journals.lww.com
Aim: To analyze the correlation between [18 F]-fluoro-2-deoxy-D-glucose (18 F-FDG) uptake
assessed by positron emission tomography/computed tomography (PET/CT) in breast …
assessed by positron emission tomography/computed tomography (PET/CT) in breast …
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis
N Avril, M Menzel, J Dose, M Schelling… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Breast cancer is characterized by elevated glucose consumption resulting in increased
uptake of 18F-FDG. However, tracer uptake varies considerably among tumors imaged with …
uptake of 18F-FDG. However, tracer uptake varies considerably among tumors imaged with …
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
R Bos, JJM Van der Hoeven, E Van der Wall… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: Variable uptake of the glucose analog 18fluorodeoxyglucose (FDG) has been
noticed in positron emission tomography (PET) studies of breast cancer patients, with low …
noticed in positron emission tomography (PET) studies of breast cancer patients, with low …
Related searches
- breast cancer blood flow
- neoadjuvant chemotherapy blood flow
- breast cancer neoadjuvant chemotherapy
- neoadjuvant chemotherapy changes in response
- breast cancer changes in response
- breast cancer glucose metabolism
- fdg metabolism blood flow
- breast cancer fdg uptake
- breast cancer tissue analysis
- breast cancer retention index
- tissue analysis glucose metabolism
- tumor phenotype chemotherapy response
- fdg metabolism breast cancers